Insufficient scRNA-seq data for expression of SEMG2 at single-cell level.
Insufficient scRNA-seq data for expression of SEMG2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 86% | 5701.82 | 210 / 245 | 31% | 35.91 | 154 / 502 |
| kidney | 75% | 26.61 | 67 / 89 | 0% | 0.00 | 2 / 901 |
| bladder | 29% | 203.86 | 6 / 21 | 6% | 0.78 | 28 / 504 |
| skin | 14% | 1.31 | 262 / 1809 | 1% | 0.10 | 4 / 472 |
| esophagus | 6% | 1.75 | 83 / 1445 | 7% | 0.22 | 12 / 183 |
| breast | 10% | 14.89 | 44 / 459 | 1% | 0.16 | 12 / 1118 |
| stomach | 4% | 0.51 | 16 / 359 | 6% | 0.32 | 16 / 286 |
| intestine | 5% | 0.59 | 52 / 966 | 4% | 0.24 | 22 / 527 |
| lung | 5% | 0.33 | 29 / 578 | 2% | 0.12 | 23 / 1155 |
| uterus | 4% | 0.34 | 6 / 170 | 2% | 0.08 | 8 / 459 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.70 | 2 / 45 |
| peripheral blood | 4% | 0.28 | 34 / 929 | 0% | 0 | 0 / 0 |
| adipose | 4% | 1.40 | 43 / 1204 | 0% | 0 | 0 / 0 |
| thymus | 3% | 0.32 | 20 / 653 | 0% | 0.15 | 3 / 605 |
| muscle | 3% | 0.32 | 28 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 2% | 0.19 | 6 / 258 | 1% | 0.03 | 2 / 230 |
| brain | 3% | 0.19 | 78 / 2642 | 0% | 0.12 | 1 / 705 |
| ovary | 3% | 0.46 | 5 / 180 | 0% | 0.01 | 1 / 430 |
| blood vessel | 3% | 0.23 | 38 / 1335 | 0% | 0 | 0 / 0 |
| pancreas | 2% | 0.13 | 7 / 328 | 0% | 0 | 0 / 178 |
| heart | 2% | 0.18 | 18 / 861 | 0% | 0 | 0 / 0 |
| spleen | 2% | 0.28 | 5 / 241 | 0% | 0 | 0 / 0 |
| liver | 2% | 0.27 | 4 / 226 | 0% | 0 | 0 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0050817 | Biological process | coagulation |
| GO_1901318 | Biological process | negative regulation of flagellated sperm motility |
| GO_0048240 | Biological process | sperm capacitation |
| GO_1900005 | Biological process | positive regulation of serine-type endopeptidase activity |
| GO_0019731 | Biological process | antibacterial humoral response |
| GO_0005615 | Cellular component | extracellular space |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005634 | Cellular component | nucleus |
| GO_0002020 | Molecular function | protease binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0008270 | Molecular function | zinc ion binding |
| Gene name | SEMG2 |
| Protein name | Semenogelin-2 (Semenogelin II) (SGII) Semenogelin-2 (Semenogelin II) |
| Synonyms | |
| Description | FUNCTION: Participates in the formation of a gel matrix (sperm coagulum) entrapping the accessory gland secretions and ejaculated spermatozoa. FUNCTION: Participates in the formation of a gel matrix (sperm coagulum) entrapping the accessory gland secretions and ejaculated spermatozoa. . FUNCTION: Participates in the formation of a gel matrix (sperm coagulum) entrapping the accessory gland secretions and ejaculated spermatozoa. . |
| Accessions | A0JLP3 Q6IRW3 Q02383 ENST00000372769.4 |